Literature DB >> 21458073

Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels.

Andrew W Lee1, Nan Wang, Tara M C Hornell, James J Harding, Chetan Deshpande, Laura Hertel, Vashti Lacaille, Achal Pashine, Claudia Macaubas, Edward S Mocarski, Elizabeth D Mellins.   

Abstract

Human cytomegalovirus (HCMV) productively infects CD34(+) progenitor-derived, mature Langerhans-type dendritic cells (matLC) and reduces surface expression of MHC class II complexes (MHC II) by increasing intracellular retention of these molecules. To determine whether HCMV also inhibits MHC II expression by other mechanisms, we assessed mRNA levels of the class II transcriptional regulator, CIITA, and several of its target genes in infected matLC. Levels of CIITA, HLA-DRA (DRA) and DRB transcripts, and new DR protein synthesis were compared in mock-infected and HCMV-infected cells by quantitative PCR and pulse-chase immunoprecipitation analyses, respectively. CIITA mRNA levels were significantly lower in HCMV-infected matLC as compared to mock-infected cells. When assessed in the presence of Actinomycin D, the stability of CIITA transcripts was not diminished by HCMV. Analysis of promoter-specific CIITA isoforms revealed that types I, III and IV all were decreased by HCMV, a result that differs from changes after incubation of these cells with lipopolysaccharide (LPS). Exposure to UV-inactivated virus failed to reduce CIITA mRNA levels, implicating de novo viral gene expression in this effect. HCMV-infected matLC also expressed lower levels of DR transcripts and reduced DR protein synthesis rates compared to mock-infected matLC. In summary, we demonstrate that HCMV infection of a human dendritic cell subset inhibits constitutive CIITA expression, most likely at the transcriptional level, resulting in reduced MHC II biosynthesis. We suggest this represents a new mechanism of modulation of mature LC by HCMV.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458073      PMCID: PMC3086682          DOI: 10.1016/j.molimm.2011.02.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  62 in total

1.  Human cytomegalovirus disrupts constitutive MHC class II expression.

Authors:  Colleen M Cebulla; Daniel M Miller; Yingxue Zhang; Brian M Rahill; Peter Zimmerman; John M Robinson; Daniel D Sedmak
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

2.  Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy.

Authors:  M J Raftery; M Schwab; S M Eibert; Y Samstag; H Walczak; G Schönrich
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

3.  Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.

Authors:  N S Patil; A Pashine; M P Belmares; W Liu; B Kaneshiro; J Rabinowitz; H McConnell; E D Mellins
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

4.  Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B.

Authors:  K A Simmen; J Singh; B G Luukkonen; M Lopper; A Bittner; N E Miller; M R Jackson; T Compton; K Früh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 5.  The MHC class II transactivator: prey and hunter in infectious diseases.

Authors:  R S Accolla; A De Lerma Barbaro; S Mazza; C Casoli; A De Maria; G Tosi
Journal:  Trends Immunol       Date:  2001-10       Impact factor: 16.687

6.  Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.

Authors:  Matthew A Smith; Gabriela Wright; Jian Wu; Prafullakumar Tailor; Keiko Ozato; Xianghong Chen; Sheng Wei; Janet F Piskurich; Jenny P-Y Ting; Kenneth L Wright
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

7.  Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.

Authors:  Rish K Pai; David Askew; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

8.  The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.

Authors:  K Inaba; S Turley; T Iyoda; F Yamaide; S Shimoyama; C Reis e Sousa; R N Germain; I Mellman; R M Steinman
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

9.  Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene.

Authors:  J M Waldburger; T Suter; A Fontana; H Acha-Orbea; W Reith
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

10.  Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression.

Authors:  S Landmann; A Mühlethaler-Mottet; L Bernasconi; T Suter; J M Waldburger; K Masternak; J F Arrighi; C Hauser; A Fontana; W Reith
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

View more
  21 in total

1.  Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.

Authors:  Laura Pisapia; Giovanna Del Pozzo; Pasquale Barba; Alessandra Citro; Paul E Harris; Antonella Maffei
Journal:  Results Immunol       Date:  2012-09-27

2.  Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.

Authors:  Praneet K Sandhu; Nicholas J Buchkovich
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

3.  Human cytomegalovirus infection of langerhans-type dendritic cells does not require the presence of the gH/gL/UL128-131A complex and is blocked after nuclear deposition of viral genomes in immature cells.

Authors:  Elvin J Lauron; Dong Yu; Anthony R Fehr; Laura Hertel
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

Review 4.  Evidence linking HHV-6 with multiple sclerosis: an update.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Curr Opin Virol       Date:  2014-10-17       Impact factor: 7.090

Review 5.  Molecular mechanism and cellular function of MHCII ubiquitination.

Authors:  Jaehak Oh; Jeoung-Sook Shin
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

6.  Human CD4+ T cell response to human herpesvirus 6.

Authors:  Maria-D Nastke; Aniuska Becerra; Liusong Yin; Omar Dominguez-Amorocho; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

7.  Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model.

Authors:  Margaret M Huang; Verity G Kew; Kevin Jestice; Mark R Wills; Matthew B Reeves
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

8.  Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells.

Authors:  Roxanne Coronel; Sachiko Takayama; Timothy Juwono; Laura Hertel
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

Review 9.  Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation.

Authors:  Katherine S Forsyth; Laurence C Eisenlohr
Journal:  Curr Opin Immunol       Date:  2016-04-24       Impact factor: 7.486

Review 10.  Human cytomegalovirus tropism for mucosal myeloid dendritic cells.

Authors:  Laura Hertel
Journal:  Rev Med Virol       Date:  2014-06-02       Impact factor: 6.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.